GB9724786D0 - Oral delivery system - Google Patents

Oral delivery system

Info

Publication number
GB9724786D0
GB9724786D0 GBGB9724786.0A GB9724786A GB9724786D0 GB 9724786 D0 GB9724786 D0 GB 9724786D0 GB 9724786 A GB9724786 A GB 9724786A GB 9724786 D0 GB9724786 D0 GB 9724786D0
Authority
GB
United Kingdom
Prior art keywords
delivery system
oral delivery
oral
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9724786.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10822541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB9724786(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Priority to GBGB9724786.0A priority Critical patent/GB9724786D0/en
Publication of GB9724786D0 publication Critical patent/GB9724786D0/en
Priority to PCT/GB1998/003511 priority patent/WO1999026652A1/en
Priority to EP98958993A priority patent/EP1051188A1/en
Priority to JP2000521854A priority patent/JP2001523728A/en
Priority to CA002310775A priority patent/CA2310775A1/en
Priority to AU14934/99A priority patent/AU739270B2/en
Priority to NO20002647A priority patent/NO20002647L/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
GBGB9724786.0A 1997-11-25 1997-11-25 Oral delivery system Ceased GB9724786D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9724786.0A GB9724786D0 (en) 1997-11-25 1997-11-25 Oral delivery system
PCT/GB1998/003511 WO1999026652A1 (en) 1997-11-25 1998-11-25 Mucosal delivery system comprising lipophilic thrombin inhibitors
EP98958993A EP1051188A1 (en) 1997-11-25 1998-11-25 Mucosal delivery system comprising lipophilic thrombin inhibitors
JP2000521854A JP2001523728A (en) 1997-11-25 1998-11-25 Mucosal delivery system with lipophilic thrombin inhibitor
CA002310775A CA2310775A1 (en) 1997-11-25 1998-11-25 Mucosal delivery system comprising lipophilic thrombin inhibitors
AU14934/99A AU739270B2 (en) 1997-11-25 1998-11-25 Mucosal delivery system comprising lipophilic thrombin inhibitors
NO20002647A NO20002647L (en) 1997-11-25 2000-05-24 Mucosal administration system comprising lipophilic thrombin inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9724786.0A GB9724786D0 (en) 1997-11-25 1997-11-25 Oral delivery system

Publications (1)

Publication Number Publication Date
GB9724786D0 true GB9724786D0 (en) 1998-01-21

Family

ID=10822541

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9724786.0A Ceased GB9724786D0 (en) 1997-11-25 1997-11-25 Oral delivery system

Country Status (7)

Country Link
EP (1) EP1051188A1 (en)
JP (1) JP2001523728A (en)
AU (1) AU739270B2 (en)
CA (1) CA2310775A1 (en)
GB (1) GB9724786D0 (en)
NO (1) NO20002647L (en)
WO (1) WO1999026652A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1400245B1 (en) * 2002-09-09 2006-05-03 Trigen Limited Boronic acid salts useful in parenteral formulations for selective thrombin inhibition
US7371729B2 (en) 2002-09-09 2008-05-13 Trigen Limited Boronic acid salts useful in parenteral formulations
GB0405272D0 (en) * 2004-03-09 2004-04-21 Trigen Ltd Compounds
GB0405280D0 (en) * 2004-03-09 2004-04-21 Trigen Ltd Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions
WO1994020526A1 (en) * 1993-03-03 1994-09-15 Sandoz Ltd. Peptide boronic acid derivatives having protease inhibiting activity

Also Published As

Publication number Publication date
EP1051188A1 (en) 2000-11-15
AU739270B2 (en) 2001-10-11
NO20002647D0 (en) 2000-05-24
CA2310775A1 (en) 1999-06-03
AU1493499A (en) 1999-06-15
WO1999026652A1 (en) 1999-06-03
NO20002647L (en) 2000-05-24
JP2001523728A (en) 2001-11-27

Similar Documents

Publication Publication Date Title
SG80049A1 (en) Delivery system
HUP9903658A3 (en) Buccal delivery system
HUP0300246A3 (en) Delivery system
EP1115377A4 (en) Semi-moist oral delivery system
EP1015971A4 (en) Reliable event delivery system
PL340337A1 (en) Drugs
EP1061987A4 (en) Drug delivery system
AU8374498A (en) Combination counter-ejector shingle-output delivery system
EP0989878A4 (en) Drug delivery system
ZA975339B (en) Perfume delivery system
GB9702021D0 (en) Medicaments
GB9722939D0 (en) Delivery service
SG79983A1 (en) Conveying system
GB9721367D0 (en) Delivery system
EP1021137A4 (en) Drug delivery system
EP0913159A4 (en) Drug delivery system using galactoxyloglucan
GB9724786D0 (en) Oral delivery system
GB9404293D0 (en) Drug delivery system
GB9706236D0 (en) Cement delivery system
GB2337520B (en) Delivery system
GB9402420D0 (en) Oral delivery system
GB9600471D0 (en) Drug delivery system
GB9811152D0 (en) Delivery system
GB9700355D0 (en) Drug delivery system
GB9612466D0 (en) Delivery system

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)